An integrated GLP-1 program is utilizing medications that have received approval from the FDA.
Steady: 1 in the last 7 days
Updated thursday
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An integrated GLP-1 program is utilizing medications that have received approval from the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The FDA approved the first oral GLP-1 agonist, which requires higher doses and increased manufacturing costs.Sub-event
Integrated GLP-1 program uses FDA-approved medications.1 source
Keep exploring
The entities involved
Related events
- BMS, Eli Lilly, and Novo Nordisk are advancing GLP-1 portfolios, investing in manufacturing, and navigating regulatory approvals.
- Eli Lilly and Company received full FDA approval, expanded a safety study into India, and broke ground on a new facility in Houston while competing in the GLP-1 market.
- Both the FDA and the European Medicines Agency govern drug approval processes.